Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Julphar
Dow
US Department of Justice
Accenture
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Merck

Generated: November 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,978,945

« Back to Dashboard

Which drugs does patent 6,978,945 protect, and when does it expire?

Patent 6,978,945 protects EVAMIST and is included in one NDA.

This patent has seventeen patent family members in ten countries.

Summary for Patent: 6,978,945
Title: Dispensing device
Abstract:Hand-held dispensing devices for dispensing and applying a substance to the skin of a host are described. The devices include a hollow body, a capsule mounted within the hollow body for containing the substance, a nozzle mounted within the hollow body communicating with the substance in the capsule, an actuator to cause metered quantities of the substance to be dispensed from the capsule through the nozzle, a shroud defining an exit space for receiving the substance emerging from the nozzle, and a cap detachably mounted on the shroud to selectively open and close the nozzle and thereby control escape of the substance from the capsule.
Inventor(s): Wong; Kon Euan (Glen Waverly, AU), Bayly; Mark Simon (Eltham North, AU)
Assignee: Acrux DDS Pty Ltd (AU)
Application Number:10/442,323
Patent Claim Types:
see list of patent claims
Dosage form; Device; Composition; Formulation;

Drugs Protected by US Patent 6,978,945

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Perrigo Pharma Intl EVAMIST estradiol SPRAY;TRANSDERMAL 022014-001 Jul 27, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,978,945

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPR1845Dec 01, 2000

International Family Members for US Patent 6,978,945

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2002220352 ➤ Try a Free Trial
Australia 2005234689 ➤ Try a Free Trial
Australia 2035202 ➤ Try a Free Trial
Canada 2436882 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Chinese Patent Office
Argus Health
UBS
Cantor Fitzgerald
Harvard Business School
McKesson
Accenture
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.